Articles

A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies

Div of Hematology Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, USA;
Hematology Division, Brigham and Womens Hospital, Boston, USA;
Div of Hematology Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, USA;
Division of Hematology Oncology, Newton-Wellesley Hospital, Newton, USA;
Hematology Division, Brigham and Women Hospital, Harvard Medical School, Boston, USA
Div of Hematology Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, USA;
Haematologica Early view Jun 4, 2020 https://doi.org/10.3324/haematol.2020.251900